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About 15 million children are born under 37 weeks of gestation worldwide. Prematurity is
the leading cause of neonatal deaths and short/long term morbidities, entailing conse-
quences not only for the individual, but also their family, health agencies, facilities and all
community. The provider-initiated preterm birth is currently one of the most important
obstetric conditions related to preterm births, particularly in middle and high income coun-
tries, thus decreasing the need for therapeutic preterm birth is essential to reduce global
prematurity. Therefore detailed knowledge on the factors associated with provider-initiated
preterm birth is essential for the efforts to reduce preterm birth rates and its consequences.
In this current analysis we aimed to assess the proportion of provider-initiated (pi-PTB)
among preterm births in Brazil and identify associated factors.
Methods and Findings
This is an analysis of a multicenter cross-sectional study with a nested case-control compo-
nent called Brazilian Multicenter Study on Preterm Birth (EMIP). EMIP was conducted in 20
referral obstetric hospitals located in the three most populated of the five Brazilian regions.
We analysed data of women with pi-PTB, defined as childbirth occurring at less than 37
weeks, medically indicated for maternal/fetal compromise or both; and women with term
birth, childbirth at or after 37 weeks. Maternal, sociodemographic, obstetric, prenatal care,
delivery, and postnatal characteristics were assessed as possible factors associated with
pi-PTB, compared to term births. The overall prevalence of preterm births was 12.3%. Of
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these, approximately one-third of cases were initiated by the provider. Hypertensive disor-
ders, placental abruption, and diabetes were the main maternal conditions leading to pi-
PTB. Caesarean section was the most common mode of delivery. Chronic hypertension
(OR 7.47; 95%CI 4.02–13.88), preeclampsia/eclampsia/HELLP syndrome (OR 15.35;
6.57–35.88), multiple pregnancy (OR 12.49; 4.86–32.05), and chronic diabetes (OR 5.24;
2.68–10.25) were the most significant factors independently associated with pi-PTB.
Conclusions
pi-PTB is responsible for about one-third of all preterm births, requiring special attention.
The decision-making process relative to the choice of provider-initiated birth is complex,
and many factors should be elucidated to improve strategies for its prevention, including evi-
dence-based guidelines on proper management of the corresponding clinical conditions.
Introduction
TheWorld Health Organization (WHO) estimates that the worldwide incidence of preterm
births is 15 million annually, accounting for 11.1% of all births [1]. More recently, the preva-
lence of preterm births in Brazil has been estimated to range from 9.9% [1] to 12.3% [2]. The
main conditions leading to preterm birth are spontaneous preterm labor, preterm premature
rupture of membranes (pPROM) or provider-initiated (medically indicated) delivery, due to
maternal or fetal indications [3–5]. Contributing factor vary widely among different regions or
countries [6,7]. There is some indication that the substantial rise in preterm births observed
during the last few decades may be explained by growing pi-PTB rates [3].
Multiple risk factors play a role in such distinct rates. Pi-PTB is recurrently associated with
either maternal pathological conditions (severe preeclampsia, eclampsia, placental abruption,
placenta previa, and other severe maternal clinical conditions); or fetal conditions (fetal growth
restriction, fetal distress or even fetal malformations). In addition, some maternal characteris-
tics and morbidities including age, race/ethnicity, body mass index, assisted reproductive pro-
cedures, hypertension, diabetes, and others are closely linked to a higher pi-PTB risk [4,7–10].
The WHOMulticountry Survey analysed more than 300,000 births, concluding that mater-
nal age>35, nulliparity, previous C-section, anaemia, malaria/dengue, chronic hypertension,
and preeclampsia/eclampsia were maternal conditions associated with pi-PTB. Furthermore,
stillbirth and early neonatal death rates were higher in pi-PTB than in spontaneous preterm
births (sPTB) [6].
Preterm birth is the current leading cause of neonatal mortality. It is also responsible for
more than half of long-term neonatal morbidities [11–13]. However, death rates resulting from
prematurity have not shown the same reduction as global neonatal mortality rates in recent
decades [11]. A study from 192 countries showed that the lower the neonatal mortality rate,
the higher the importance of prematurity in the etiology of neonatal death. Despite the
decrease of neonatal mortality, the preterm component remains static. In some cases, it is even
higher and most likely attributed to pi-PTB [14].
A decrease in pi-PTB is essential to reduce global prematurity and its resultant neonatal
morbidity and mortality [4,13], particularly in middle-, high- and very high-income countries
[6], as part of effective preventive strategies for the preconception or postconceptional periods
[15–17]. It is then fundamental to investigate the underlying conditions related to pi-PTB in
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different backgrounds [15,18]. Therefore, we intend to identify the prevalence, characteristics
and main factors associated with pi-PTB, as well as corresponding perinatal outcomes in the
Brazilian Multicentre Study of Preterm Birth (EMIP) [19,20].
Methods
Ethics statement
The proposal for this study has been reviewed and approved by the National Council for Ethics
in Research (CONEP) and by the Institutional Review Board of each site. Before enrolment, an
individual Informed Consent form was signed by each subject after understanding and accept-
ing the study conditions. The confidentiality of identity was ensured regardless of whether the
women participated in the study or not. The study totally complies with The Declaration of
Helsinki, following Brazilian National Health Council Resolution 196/96.
The Review Boards of the following institutions reviewed and approved this study: Materni-
dade Climério de Oliveira (Salvador, BA), Maternidade Escola Assis Chateaubriand (Fortaleza,
CE), Hospital Universitário da Universidade Federal do Maranhão (Sao Luis, MA), Instituto de
Saúde Elídio de Almeida (Campina Grande, PB), Hospital Universitário Lauro Wanderley da
Universidade Federal da Paraíba (Joao Pessoa, PB), Instituto de Medicina Integral Prof. Fer-
nando Figueira (Recife, PE), Hospital das Clınicas da Universidade Federal de Pernambuco
(Recife, PE), Hospital das Clınicas da Universidade Federal do Paraná (Curitiba, PR), Instituto
Fernandes Figueira (Rio de Janeiro, RJ), Hospital das Clinicas da Universidade Federal do Rio
Grande do Sul (Porto Alegre, RS), Faculdade de Medicina de Botucatu da Universidade Esta-
dual Paulista (Botucatu, SP), Hospital da Mulher da Universidade Estadual de Campinas
(Campinas, SP), Maternidade Escola de Vila Nova Cachoeirinha (São Paulo, SP), Hospital
Estadual de Sumaré (Sumaré, SP), Faculdade de Medicina de Jundiaí (Jundiaí, SP), Hospital
das Clınicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (Ribei-
rão Preto, SP), Santa Casa de Limeira (Limeira, SP), Santa Casa de São Carlos (São Carlos, SP),
Casa Maternal Leonor Mendes de Barros (São Paulo, SP), and Hospital São Paulo da Universi-
dade Federal de São Paulo (São Paulo, SP).
Study design, population and sample size
The Brazilian Multicentre Study on Preterm Birth (EMIP) took place in 20 referral obstetric
hospitals located in the three most populated regions of Brazil. Methodological details of this
study were published elsewhere [19,21]. Briefly, this cross-sectional study carried out surveil-
lance of 33,740 deliveries from April 2011 to July 2012. A dataset of all preterm deliveries and
preterm infants was established to allow the descriptive evaluation of each one of the three
components (spontaneous preterm birth, preterm birth following a premature rupture of
membranes, and a therapeutic or provider-initiated preterm birth). In addition, we also imple-
mented a nested unmatched case-control component to compare preterm births with a term-
birth sample, considering the limitation for a cohort study and getting information for all
births during the period. A term birth immediately after a preterm birth was included as a
proxy for a randomly selected control group, if the women agreed to participate, until reaching
the previously estimated sample size. Otherwise, the next term birth was approached. Sample
calculation for the whole study was based on the Brazilian preterm birth prevalence of 6.5% in
2006 and at least 1054 subjects per group for the case-control component [2,19,22].
During the data collection period, each participating centre monitored preterm births con-
tinuously to identify women eligible for the study. Once identified, women were invited to par-
ticipate. After receiving explanations, agreeing to participate and signing a consent term, these
women were enrolled. Information was collected through three sources: postpartum interview
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using a structured questionnaire and medical chart review. Neonatal data was collected up to
hospital discharge or up to sixty days after birth if the neonate remained admitted.
Variables and outcomes
The main outcome for this analysis was pi-PTB, defined as childbirth occurring at less than 37
weeks, medically indicated for maternal/fetal compromise or both; or term birth, childbirth at
or after 37 weeks. Preterm birth were classified as extremely preterm (before 28 completed
weeks), very preterm (from 28 to 31 completed weeks) and moderately preterm (from 32 to 36
completed weeks), according to the World Health Organization [1]. Data on another separate
category including only late preterm births (from 34 to 36 completed weeks) was reported [23].
Other secondary outcomes were admission to neonatal intensive care unit (NICU); Apgar
score< 7 at 5 minutes; low birth weight (<2500g); and neonatal mortality.
Variables assessed as potential predictors of pi-PTB were related to sociodemographic char-
acteristics, working status, maternal weight assessment, reproductive and obstetric history, pre-
natal care (including adequate number of prenatal care visits for gestational age, previously
defined by the Brazilian Ministry of Health [24]), lifestyle and habits, data on short cervix (clin-
ical history or cervical length< 25 mmmeasured between 14 to 24 weeks by vaginal ultra-
sound scan), suspected cervical insufficiency (clinical or ultrasound signs), cerclage during
pregnancy, uterine fibroid, vaginal bleeding, oligohydramnios or polyhydramnios, fetal malfor-
mation, fetal growth restriction, multiple pregnancy, features of maternal and fetal care, and
maternal and/or fetal indication for delivery. For defining all these variables we used a prag-
matic approach using information reported in medical records by providers of care considering
clinical and ultrasonographic aspects according to the standard procedures of each participat-
ing centre.
Data quality
Several procedures were adopted to ensure high-quality data and reliable information, includ-
ing preparatory meetings, use of a detailed manual of operation, site visits, technical visits to
participating centers, closely monitored data collection and data entry, concurrent query man-
agement, inconsistency checks, and database correction [20].
Statistical analysis
Initially the pi-PTB prevalence was estimated among all preterm births occurring in participat-
ing centres during the data collection period. Estimation was stratified based on geographical
region, gestational age, delivery indications, and clinical management. Delivery indications,
maternal and neonatal outcomes were distributed according to gestational age, and evaluated
by χ2 tests.
Bivariate analyses were then conducted to identify and estimate risks of pi-PTB, using the
Odds Ratio (OR) with 95% confidence intervals (CI) for each predictor (sociodemographic,
obstetric history and current pregnancy conditions), adjusting for clustering effect design. To
identify factors independently associated with pi-PTB and to control for confounding, a multi-
variate analysis using non-conditional multiple logistic regression was performed, reporting
the estimated adjusted ORadj with a 95% CI. Backward stepwise regression was performed
including all variables in the logistic regression model. Missing data were excluded from analy-
sis and are detailed reported in the tables´ footnotes. Each centre was considered a cluster. Low
intracluster correlation coefficients for variables were considered appropriate, since centers
heterogeneity strengthen sample representation [21].
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Statistical analysis was carried out using SPSS version 20.0 (SPSS, Chicago, IL, USA) and
Stata version 7.0 (StataCorp, College Station, TX, USA). A p-value<0.05 was considered
significant.
Results
EMIP carried out surveillance of 33,740 births in 20 participating centres, identifying 1,468 pi-
PTBs, and selecting a sample of 1,146 term births (Fig 1). The total prevalence of preterm birth
was 12.3%. During the study period, 9.37% of women having preterm births in the participat-
ing centres were not enrolled due to some very few refusals and mainly due to hospital dis-
charge before they could be approached by the interviewers.
The proportion of pi-PTB among all preterm births was 35.4%, ranging from 34.7% in the
Southeast to 39.6% in the South of Brazil. The Southeast region accounted for the majority of
the pi-PTB (54.1%), while only 14% occurred in the South in this sample (Table 1). Multiple
pregnancies occurred in 7.7% of pi-PTB, representing 25.9% of all preterm multiple births
identified. More than three-quarters (76.7%) of births occurred between 32 and 36 weeks,
while the lowest proportion occurred in pregnancies less than 28 weeks (6.9%). The late pi-
PTB (34–36 weeks) corresponded to almost 60% of them.
Exclusive maternal condition was the main indication for delivery in 45.9% of pi-PTB.
Hypertensive disorders (preeclampsia– 58.2%, chronic hypertension– 15.3%, gestational
hypertension– 12.9%, and HELPP syndrome– 9.4%) were the most common indications,
regardless of gestational age (Tables 1 and 2). HELLP syndrome, placental abruption and chor-
ioamnionitis occurred more frequently before 32 weeks. Fetal distress and fetal growth restric-
tion (FGR) were the most important fetal indications in all gestational ages (Table 2). It shows
that major fetal surveillance methods used were Doppler ultrasound and cardiotocography,
while fetal movement counting was rarely employed. Table 2 also shows that only 58.2% of
women with pregnancies interrupted at less than 28 weeks received antenatal corticosteroids
(ACS). However, almost three-quarters of women between 28–31 weeks received corticoste-
roids for fetal lung maturation at least once during pregnancy.
Fig 2 shows that the proportion of vaginal delivery was only 11.4% in pi-PTB and 56.7% in
term births. The prevalence of vaginal delivery before 28 weeks doubled in comparison to
Fig 1. Flow chart of subjects in the Brazilian Multicentre Study on Preterm Birth.
doi:10.1371/journal.pone.0148244.g001
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other gestational ages, although it was only 26.7%. Neonatal outcomes in preterm groups were
much worse than in the term group, even comparing the 34–36 week group to the term group
(Fig 3). Neonatal death before discharge was more than 200 times higher in the subgroup
under 28 weeks and 54 times higher in the 28–31 week subgroup than in the term group. The
difference is still significant between the 34–36 week group and the term group (6.3-fold).
Regarding tests supporting the decision to deliver and obstetric care characteristics accord-
ing to indication for pregnancy interruption among pi-PTB, Doppler ultrasound was the most
frequently used test in fetal or maternal/fetal indications (43.8% and 46.4%, respectively).
When maternal compromise indicated pregnancy interruption, haematological (27.7%) and
liver function panel (23.5%) were the most common tests ordered. The attempts to treat the
clinical condition causing pi-PTB and ACS use were lower in fetal (29.2% and 32.8%, respec-
tively) than in maternal indication (66.9% and 43.3%, respectively) or maternal and fetal
Table 1. Prevalence of provider-initiated preterm births in a sample of selected tertiary referral Brazilianmaternities according to geographical
region, gestational age and delivery indications.
Provider-initiated Preterm births
n (%)
Proportion of provider-initiated delivery among all preterm
deliveries (%)
BRAZIL (total) 1,468 (100) 35.4
Region
Southeast 794 (54.1) 34.7
Northeast 468 (31.9) 34.9
South 206 (14.0) 39.6
Gestational age at delivery
<28 weeks 101 (6.9) 32.8
28–31 weeks 241 (16.4) 42.1
32–36 weeks 1126 (76.7) 34.4
34–36 weeks 859 (58.5) 33.0
Multiple pregnancy 113 (7.7) 25.9
Indication of pregnancy interruption (a)
Maternal 670 (45.9)
Fetal 370 (25.4)
Maternal and Fetal 419 (28.7)
Maternal indication for interruption *
[n = 1084] (b)
Preeclampsia 631 (58.2)
Chronic hypertension 166 (15.3)
Gestational hypertension 140 (12.9)
HELLP syndrome 102 (9.4)
Placental abruption 83 (7.7)
Diabetes 79 (7.3)
Placenta previa 36 (3.3)
Non-obstetric infection 16 (1.5)
Maternal cardiac disease 12 (1.1)
Chorioamnionitis 6 (0.6)
Others** 96 (8.8)
*Indications are not mutually exclusive.
**Miscalculation of gestational age, maternal injury, pulmonary hypertension, autoimmune disease, delivery by maternal request.
Missing information for: (a) 9; (b) 5 cases.
doi:10.1371/journal.pone.0148244.t001
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(68.5% and 49.6%, respectively). However, no difference was identified in treatment duration
between both conditions (data not shown).
Case assessment of estimated pi-PTB risk showed that maternal age 19 had a 28% lower
risk, while> 12 years of schooling had a 64% higher risk, and maternal age 35 had a 99%
higher risk. Furthermore, having children aged 5 years or younger exerted a protective effect.
On the other hand, some obstetric conditions were associated with increased pi-PTB risk, e.g.
previous C-section, inter-pregnancy interval 12 months, previous preterm birth and previ-
ous newborn under 2500g (Tables 3 and 4).
Table 2. Fetal andmaternal indications for pregnancy interruption and characteristics of obstetric care according to gestational age in provider-
initiated preterm births (n = 1,468).
Gestational age
Indications for pregnancy interruption and characteristics of
obstetric care




Maternal indication for interruption [n = 1084] (a)
Preeclampsia 39 (54.9) 120 (65.9) 472 (56.8) 0.157 358 (55.8)
Chronic hypertension 8 (11.3) 32 (17.6) 126 (15.2) 0.452 98 (15.3)
HELLP syndrome 10 (14.1) 31 (17.0) 61 (7.3) <0.001 38 (5.9)
Placental abruption 12 (16.9) 17 (9.3) 54 (6.5) 0.010 35 (5.5)
Gestational hypertension 6 (8.5) 22 (12.1) 112 (13.5) 0.338 88 (13.7)
Placenta previa 4 (5.6) 8 (4.4) 24 (2.9) 0.433 21 (3.3)
Eclampsia 2 (2.8) 4 (2.2) 29 (3.5) 0.571 25 (3.9)
Diabetes 0 (-) 5 (2.7) 74 (8.9) 0.086 64 (10.0)
Chorioamnionitis 2 (2.8) 1 (0.5) 3 (0.4) 0.045 3 (0.5)
Non-obstetrical infection 0 (-) 2 (1.1) 14 (1.7) 0.537 13 (2.0)
Maternal cardiopathy 0 (-) 3 (1.6) 9 (1.1) 0.503 9 (1.4)
Placental insufficiency 1 (1.4) 3 (1.6) 8 (1.0) 0.713 3 (0.5)
Others# 5 (7.0) 2 (1.1) 77 (9.3) <0.001 66 (10.3)
Fetal indication for interruption [n = 1427] (b)
Fetal distress 33 (47.8) 89 (60.5) 326 (57.2) 0.380 221 (54.4)
Fetal growth restriction 15 (21.7) 61 (41.5) 189 (33.2) 0.051 129 (31.8)
Fetal malformation 11 (15.9) 6 (4.1) 52 (9.1) 0.026 38 (9.4)
Others 25 (36.2) 41 (27.9) 131 (23.0) 0.047 100 (24.6)
Fetal monitoring methods [n = 1348] (c)
Doppler ultrasound 57 (60.6) 155 (68.3) 612 (59.6) 0.253 439 (56.8)
Cardiotocography 30 (31.9) 118 (52.0) 674 (65.6) <0.001 519 (67.1)
Fetal biophysical profile 28 (29.8) 88 (38.8) 318 (31.0) 0.088 227 (29.4)
Fetal movement counting 1 (1.1) 10 (4.4) 47 (4.6) 0.319 34 (4.4)
Antenatal corticosteroids (%) [n = 1400] (d) 57 (58.2) 164 (74.5) 375 (34.7) <0.001 203 (24.5)
Multiple courses of antenatal corticosteroids [n = 560] (e) 2 (3.7) 10 (6.5) 29 (8.3) 0.385 16 (8.4)
An attempt to treat clinical condition that motivated interruption
[n = 1428] (f)
58 (58.0) 163 (69.7) 606 (55.4) 0.006 433 (52.0)







#Miscalculation of gestational age, maternal injury, pulmonary hypertension, autoimmune disease, delivery by maternal request.
P-values in bold mean they are statistically significant.
Missing information for: (a) 5; (b) 3; (c) 120; (d) 68; (e) 36; (f) 40; (g) 31.
doi:10.1371/journal.pone.0148244.t002
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Table 5 shows conditions associated with increased pi-PTB risk: fetal growth restriction
(12-fold), multiple pregnancy (9-fold), preeclampsia/eclampsia/HELLP (9-fold), oligohydram-
nios (7-fold), fetal malformation (5-fold), chronic hypertension (5-fold), chronic diabetes
(4-fold), systemic lupus erythematosus (5-fold), prenatal care not only in primary health unit
(2-fold), polyhydramnios (2-fold), gestational hypertension (2-fold), gestational diabetes
(2-fold), inadequate number of prenatal care visits (2-fold), obesity (1.8-fold), smoking during
first and second trimester (1.8-fold), overweight (1.4-fold), vaginal bleeding (1.4-fold) and
weight gain7kg (1.3-fold). Women who gained more than 12kg during pregnancy and initial
BMI< 18.5kg/m2 were at lower risk for pi-PTB.
Finally, results of multivariate analysis are in Table 6. Preeclampsia/eclampsia/HELLP
(ORadj 15.35; 95%CI 6.57–35.88) or multiple pregnancy (ORadj 12.49; 4.56–32.05) were the
highest risk factors for pi-PTB. Other hypertensive disorders (chronic hypertension and gesta-
tional hypertension), maternal morbidities (chronic diabetes, cardiac disease and systemic
lupus erythematosus) and vaginal bleeding during pregnancy also showed higher risks for pi-
PTB. The higher the maternal age or initial BMI, the higher the pi-PTB risk, whereas the higher
the final BMI, the lower the risk for pi-PTB. Non-white skin colour was identified as factor
associated with a lower pi-PTB risk.
Fig 2. Caesarean section rates according to gestational age in provider-initiated preterm birth (n = 1,468) and term births.Mode of delivery
according to theWorld Health Organization´s gestational age categories are significantly different (p<0.001).
doi:10.1371/journal.pone.0148244.g002
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PLOS ONE | DOI:10.1371/journal.pone.0148244 February 5, 2016 8 / 20
Discussion
The EMIP study corroborates a recent upward trend in national and global preterm rates [2,4].
Previous studies have shown that pi-PTB is responsible for almost one-third of preterm births
in Latin America. In higher-income populations with better access to health care, pi-PTB has
increased, remaining the fastest growing determinant of preterm birth in recent decades
Fig 3. Neonatal outcomes according to gestational age in provider-initiated preterm birth (n = 1,468) and term births.Missing information for: (a) 20;
(b) 131; (c) 5; (d) 13. All differences are statistically significant (p<0.001).
doi:10.1371/journal.pone.0148244.g003
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[3,6,7,25]. Consistent recognition of pregnancy complications and maternal morbidities using
screening protocols could partially justify the higher pi-PTB rates in middle and high-income
settings.
Pi-PTB is not only the result of provider preference when faced with either pregnancy com-
plications or prematurity consequences. It can also be a life-saving decision for both the mother
and fetus. Pregnancy interruption seems more reasonable in the “near term” (34–36 weeks)
group. Almost 60% of all pi-PTB currently occurs in this gestational age group. Nevertheless,
this decision-making emblematic scenario in the late preterm group requires careful attention,
since previous reports have described that more than 50% of late pi-PTB indications were not
evidence-based [26]. In our data, less than 50% of pi-PTB due to fetal compromise had the sup-
port of Doppler ultrasound or cardiotocography. Only about one-quarter of pi-PTB due to
maternal conditions were supported by maternal exams/tests, highlighting the importance of
evidence-based decisions.
Table 3. Risk estimates for provider-initiated preterm birth according to somematernal sociodemographic conditions.
Socio-demographic conditions CASES CONTROLS OR* (95% CI)
Provider-initiated N (%) Term birth N (%)
Maternal age (years) (a)
•  19 183(12.5) 211 (18.4) 0.72 0.61–0.85]
• 20–34 980 (66.8) 809 (70.6) 1.00
•  35 304 (20.7) 126 (11.0) 1.99 [1.48–2.68]
Skin colour/ethnicity
• White 675 (46.0) 451 (39.4) 1.00
• Other 793 (54.0) 695 (60.6) 0.76 [0.54–1.07]
Marital status
• With a partner 1175 (80.0) 919 (80.2) 1.00
• Without a partner 293 (20.0) 227 (19.8) 1.01 [0.83–1.23]
Household (b)
• Urban 1332 (91.1) 1021 89.5) 1.00
• Rural 130 (8.9) 120 (10.5) 0.83 [0.45–1.52]
Schooling (years) (c)
• 8 546(37.8) 420(37.2) 1.05 [0.93–1.30]
• 9–12 740 (51.3) 629 (55.7) 1.00
• >12 157 (10.9) 81 (7.2) 1.64 [1.23–2.20]
Paid work in pregnancy (d)
• No 843 (57.9) 690 (60.3) 1.00
• Yes 612 (42.1) 455 (39.7) 1.10 [0.87–1.39]
Workload (daily) [n = 1055] (e)
• 8 hours 445 (73.8) 324 (71.7) 1.00
• >8 hours 158 (26.5) 128 (28.3) 0.90 [0.68–1.20]
Children under 5 years (f)
• No 1136 (77.5) 821 (71.7) 1.00
• Yes 330 (22.5) 324 (28.3) 0.74 [0.60–0.90]
Total 1,468 (100) 1,146 (100)
OR*: Odds Ratio adjusted for the cluster effect design; CI: confidence interval.
Values in bold mean they are statistically significant.
Missing information for: (a) 1; (b) 11; (c) 418; (d) 14; (e) 12; (f) 3.
doi:10.1371/journal.pone.0148244.t003
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Obesity and advanced maternal age are factors related to a higher risk of preeclampsia, dia-
betes, chronic hypertension and other pregnancy complications or chronic diseases, and also
resultant pi-PTB [27–31]. The higher the BMI before pregnancy, the higher the pi-PTB risk
[30–33]. In contrast, underweight women before pregnancy and maternal age< 19 were
related to a higher sPTB risk for the EMIP population [2], but not for pi-PTB. Advanced
maternal age also increases the need for assisted fertility treatments, elevating the prevalence of
multiple pregnancy, an important condition for both pi-PTB and sPTB [4]. Brazilian women
conceive at increasingly older ages. In overweight or obese women, the scenario is unfavourable
for a healthy pregnancy [34,35]. Preconception care package including nutritional, educational
and family planning programs should be considered to prevent this situation [18].
Management of the clinical condition leading to pregnancy interruption was performed in
more than 50% of cases. The most commonly treated or prevented maternal conditions were
Table 4. Risk estimates for provider-initiated preterm birth according to maternal obstetric history.
Obstetric history CASES CONTROLS OR* (95% CI)
Provider-initiated N (%) Term birth N (%)
Parity
• Nulliparous 670 (45.6) 527 (46.0) 1.00
• 1–2 deliveries 589 (40.1) 491 (42.8) 0.94 [0.78–1.14]
 3 deliveries 209 (14.2) 128 (11.2) 1.28 [0.94–1.76]
Total 1,468 (100) 1,146 (100)
Previous caesarean section*
• No 477 (52.4) 416 (62.4) 1.00
• Yes 433 (47.6) 251 (37.6) 1.50 [1.22–1.85]
Previous abortion*
• No 540 (59.3) 435 (65.2) 1.00
• Yes 370 (40.7) 232 (34.8) 1.28 [1.00–1.66]
Inter-pregnancy interval * (a)
• > 12 months 819 (91.2) 622 (94.8) 1.00
•  12 months 79 (8.8) 34 (5.2) 1.76 [1.22–2.56]
Previous cerclage* (b)
• No 888 (98.8) 656 (98.9) 1.00
• Yes 11 (1.2) 7 (1.1) 1.16 [0.39–3.49]
Previous preterm birth* (c)
• No 641 (71.0) 565 (84.8) 1.00
• Yes 262 (29.0) 101 (15.2) 2.29 [1.79–2.93]
Previous pPROM* (d)
• No 824 (91.8) 599 (90.3) 1.00
• Yes 74 (8.2) 64 (9.7) 0.84 [0.55–1.29]
Previous newborn under 2500g* (e)
• No 656 (72.7) 571 (87.2) 1.00
• Yes 246 (27.3) 84 (12.8) 2.55 [2.00–3.25]
Total 910 (100) 667 (100)
OR*: Odds Ratio adjusted for the cluster design effect; CI: confidence interval.
*: excluded primigravida from analysis.
Values in bold mean they are statistically significant.
Missing information for: (a) 23; (b) 15; (c) 8; (d) 16; (e) 20.
doi:10.1371/journal.pone.0148244.t004
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Table 5. Risk estimates for provider-initiated preterm birth according to some conditions during pregnancy.
Conditions during pregnancy CASES CONTROLS OR* (95% CI)
Provider-initiated N (%) Term birth N (%)
Prenatal care [n = 2614]
• Yes 1439 (98.0) 1130 (98.6) 1.00
• No 29 (2.0) 16 (1.4) 1.42 [0.54–3.76]
Healthcare facility used for prenatal care [n = 2569]
• Only PHU 643 (44.7) 715 (63.3) 1.00
• PHU + hospital 250(17.4) 93 (8.2) 2.99 1.92–4.67]
• Only hospital 345(24.0) 234 (20.7) 1.64 1.18–2.28]
• Other 201 (14.0) 88 (7.8) 2.54 [1.48–4.36]
Initiation of prenatal care [n = 2218] (a)
• First trimester 792 (64.3) 645 (65.4) 1.00
• Second and third trimester 440 (35.7) 341 (34.6) 1.05 [0.79–1.40]
Adequacy of number of prenatal care visits [n = 2323] (b)
• Adequate 761 (59.5) 792 (75.8) 1.00
• Inadequate 517 (40.5) 253 (24.2) 2.13 [1.57–2.88]
Weight gain in pregnancy [n = 2283] (c)
•  7kg 360(28.4) 221 (21.7) 1.31 1.05–1.64]
• 8–12 kg 407 (32.1) 328 (32.3) 1.00
• > 12kg 500 (39.5) 467 (46.0) 0.66 [0.53–0.81]
Initial body mass index [n = 2295] (d)
• <18,5 kg/m2 56 (4.4) 84 (8.3) 0.62 [0.43–0.88]
• 18,5–24,99 kg/m2 614 (47.8) 571 (56.5) 1.00
• 25–29.99 kg/m2 346 (26.9) 218 (21.6) 1.47 [1.20–1.81]
•  30 kg/m2 269 (20.9) 137 (13.6) 1.82 [1.44–2.31]
Final body mass index [n = 2196] (e)
• <18,5 kg/m2 3 (0.2) 1 (0.1) 2.83 [0.23–34.19]
• 18,5–24,99 kg/m2 208 (16.9) 196(20.4) 1.00
• 25–29.99 kg/m2 422 (34.2) 400 (41.5) 0.99 [0.77–1.29]
•  30 kg/m2 600 (48.7) 366 (38.0) 1.54 [1.11–2.16]
Physical effort [n = 2595] (f)
• No or rarely 1184 (81.5) 896 (78.4) 1.00
• Yes (often) 268 (18.5) 247 (21.6) 0.82 [0.65–1.03]
Smoking (daily) [n = 2614]
• No 1301 (88.6) 1023 (89.3) 1.00
•  10 cigarettes 119(8.1) 84 (7.3) 1.11 [0.80–1.55]
• > 10 cigarettes 48 (3.3) 39 (3.4) 0.97 [0.59–1.58]
Smoking until (trimester) [n = 2614]
• Never or not in pregnancy 1301 (88.6) 1023 (89.3) 1.00
• First and second 62(4.2) 27 (2.4) 1.81 1.03–3.16]
• Third 105 (7.2) 96 (8.4) 0.88 [0.72–1.07]
Urinary tract infection [n = 2110] (g)
• No 823 (69.0) 645 (70.3) 1.00
• Yes 370 (31.0) 272 (29.7) 1.07 [0.84–1.35]
Short cervix (<25mm; US) [n = 1163] (h)
• No 679 (99.1 474 (99.2) 1.00
• Yes 6 (0.9) 4 (0.8) 1.05 [0.28–3.93]
Suspected cervical insufficiency (clinical or US) [n = 2291] (i)
• No 1302 (99.5) 976 (99.4) 1.00
• Yes 7 (0.5) 6 (0.6) 0.87 [0.27–2.81]
(Continued)
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Table 5. (Continued)
Conditions during pregnancy CASES CONTROLS OR* (95% CI)
Provider-initiated N (%) Term birth N (%)
Cerclage [n = 2348] (j)
• No 1330 (99.3) 1003 (99.5) 1.00
• Yes 10 (0.7) 5 (0.5) 1.51 [0.45–5.10]
Uterine fibroid [n = 2315] (k)
• No 1286 (97.5) 981 (98.5) 1.00
• Yes 33 (2.5) 15 (1.5) 1.68 [0.81–3.48]
Vaginal bleeding [n = 2610] (l)
• No 1141 (77.9) 957 (83.6) 1.00
• Yes 324 (22.1) 188 (16.4) 1.45 [1.18–1.77]
Anaemia [n = 2571] (m)
• No 1044 (72.7) 783 (69.0) 1.00
• Yes 393 (27.3) 351 (31.0) 0.84 [0.70–1.01]
Chronic Hypertension [n = 2515] (n)
• No 1233 (85.9) 1049 (97.2) 1.00
• Yes 203 (14.1) 30 (2.8) 5.76 [3.83–8.65]
Chronic Diabetes [n = 2612] (o)
• No 1399 (95.4) 1132 (98.9) 1.00
• Yes 68 (4.6) 13 (1.1) 4.23 [1.78–10.08]
Gestational diabetes [n = 2515] (n)
• No 1300 (90.5) 1030 (95.5) 1.00
• Yes 136 (9.5) 49 (4.5) 2.20 [1.16–4.16]
Gestational hypertension [n = 2515] (n)
• No 1236 (86.1) 1009 (93.5) 1.00
• Yes 200 (13.9) 70 (6.5) 2.33 [1.10–4.94]
Preeclampsia/Eclampsia/HELLP [n = 2515] (n)
• No 793 (55.2) 989 (91.7) 1.00
• Yes 643 (44.8) 90 (8.3) 8.91 [3.96–20.03]
Hypo/Hyperthyroidism [n = 2515] (n)
• No 1402 (97.6) 1062 (98.4) 1.00
• Yes 34 (2.4) 17 (1.6) 1.51 [0.71–3.23]
HIV [n = 2515] (n)
• No 1424 (99.2) 1061 (98.3) 1.00
• Yes 12 (0.8) 18 (1.7) 0.50 [0.24–1.04]
Cardiac disease [n = 2515] (n)
• No 1409 (98.1) 1069 (99.1) 1.00
• Yes 27 (1.9) 10 (0.9) 2.05 [0.89–4.72]
Renal disease [n = 2515] (n)
• No 1417 (98.7) 1069 (99.1) 1.00
• Yes 19 (1.3) 10 (0.9) 1.43 [0.66–3.10]
Lung diseases [n = 2515] (n)
• No 1414 (98.5) 1066 (98.8) 1.00
• Yes 22 (1.5) 13 (1.2) 1.28 [0.69–2.37]
Epilepsy [n = 2515] (n)
• No 1426 (99.3) 1075 (99.6) 1.00
• Yes 10 (0.7) 4 (0.4) 1.88 [0.57–6.22]
(Continued)
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decompensated hypertension and diabetes [36,37]. However, the prevention of complications
exclusively related to fetal conditions seems limited [38,39].
Caesarean section was significantly more frequent in pi-PTB than in term births, reaching
91.3% between 28 and 31 weeks. This potentially life-saving therapeutic mode of delivery
increases maternal and neonatal morbidity and mortality [40]. Some women and/or fetuses are
already at risk when a pi-PTB is indicated, therefore additional risk factors should be only con-
sidered when an evidence-based indication exists.
In the current study, more than half of pi-PTB occurred in conditions defined as ischemic
placental disease (IPD), including preeclampsia, eclampsia, HELLP syndrome, fetal growth
restriction, chronic hypertension, and placental abruption. IPD culminates in uteroplacental
underperfusion, a phenomenon mediated by many biochemical angiogenic factors and auto-
immune response regulators that are associated with its pathophysiology [41]. The hyperten-
sive disorders of pregnancy (HDP) is one of the most important “Great Obstetrical
Syndromes”, which is defined as being a condition with multiple aetiologies, having a long pre-
clinical period, being adaptive in nature, resulting in fetal involvement and being a result of
complex interaction between maternal and fetal genome and the environment [42]. HDP com-
prises four categories as chronic hypertension, gestational hypertension, preeclampsia/
Table 5. (Continued)
Conditions during pregnancy CASES CONTROLS OR* (95% CI)
Provider-initiated N (%) Term birth N (%)
Systemic lupus erythematosus [n = 2515] (n)
• No 1423 (99.1) 1077 (99.8) 1.00
• Yes 13 (0.9) 2 (0.2) 4.92 [1.21–19.98]
Thrombophilia or Thrombosis [n = 2515] (n)
• No 1429 (99.5) 1070 (99.2) 1.00
• Yes 7 (0.5) 9 (0.8) 0.58 [0.16–2.13]
Oligohydramnios [n = 2430] (p)
• No 1034 (74.2) 987 (95.2) 1.00
• Yes 359 (25.8) 50 (4.8) 6.85 [4.54–10.35]
Polyhydramnios [n = 2430] (p)
• No 1338 (96.1) 1020 (98.4) 1.00
• Yes 55 (3.9) 17 (1.6) 2.47 [1.27–4.79]
Fetal malformation [n = 2446] (q)
• No 1277 (92.1) 1043 (98.4) 1.00
• Yes 109 (7.9) 17 (1.6) 5.24 [2.57–10.68]
Fetal growth restriction [n = 2446] (q)
• No 1048 (75.6) 1033 (97.5) 1.00
• Yes 338 (24.4) 37 (2.5) 12.34 [5.70–26.73]
Multiple pregnancy [n = 2614]
• No 1355 (92.3) 1136 (99.1) 1.00
• Yes 113 (7.7) 10 (0.9) 9.47 [3.66–24.54]
Total 1468 (100) 1,146 (100)
OR*: Odds Ratio adjusted for the cluster effect design; CI: confidence interval; PHU: Primary Health Unit.
Values in bold mean they are statistically significant.
Missing information for: (a) 351; (b) 246; (c) 331; (d) 319; (e) 418; (f) 19; (g) 504; (h)1451; (i) 323; (j) 266; (k) 299; (l) 4; (m) 43; (n) 99; (o) 2; (p) 184; (q)
168.
doi:10.1371/journal.pone.0148244.t005
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eclampsia and preeclampsia superimposed on chronic hypertension. They are related with
adverse maternal and perinatal outcomes [43]. Additionally, preeclampsia, eclampsia and
chronic hypertension are of great importance for pi-PTB occurrence. Two recent WHO stud-
ies, the Multicountry Survey and Global Survey, showed that those HDP are the main risk fac-
tors for pi-PTB [6,7]. In the current study, the majority of indications was related to
hypertensive disorders, which highlights its importance in the context of preterm birth. Further
studies of IPD, especially those related to hypertensive disorders of pregnancy, could help pre-
vent this condition [44,45].
It is also important to compare factors associated with sPTB to those related to pi-PTB in
order to identify interrelationships between such complex outcomes. The population at higher
risk for each condition, neonatal outcomes and risk factors may vary depending on the main
determinant (spontaneous onset, pPROM or pi-PTB) [4,6,7,25]. Previous analyses of EMIP
showed that maternal age and years of schooling were the main factors associated with sPTB
[2]. It was demonstrated that older white women, with higher initial BMI and schooling had
more pi-PTB. This is not an indubitable phenotypic risk. A high-risk group could be at
increased risk for pi-PTB, and receive more specialized care [6]. These women have more
Table 6. Variables independently associated with provider-initiated preterm birth in all women stud-
ied: multiple analyses by non-conditional logistic regression [n = 2059].
Variables ORadj 95% CI p-value
Chronic hypertension 7.47 [4.02–13.88] <0.001
Preeclampsia/Eclampsia/HELLP 15.35 [6.57–35.88] <0.001
Final BMI (kg/m2) 0.87 [0.83–0.92] <0.001
Multiple pregnancy 12.49 [4.86–32.05] <0.001
Chronic diabetes 5.24 [2.68–10.25] <0.001
Initial BMI (kg/m2) 1.12 [1.06–1.19] <0.001
Gestational hypertension 3.87 [1.98–7.57] <0.001
Vaginal bleeding 1.64 [1.17–2.31] 0.006
Age (years) 1.02 [1.01–1.04] 0.017
Cardiac disease 2.76 [1.14–6.71] 0.027
Systemic lupus erythematosus 4.01 [1.08–14.85] 0.039
Skin colour/ethnicity (other: no white) 0.69 [0.49–0.98] 0.041
ORadj: Odds ratio adjusted for all predictors in this final model; CI: confidence interval of OR; p: p-value.
Initial predictors entering the model: age (years); skin colour/ethnicity (white: 0/ other: 1); marital status
(with a partner: 0/ without a partner: 1); household (urban: 0/ rural: 1); paid work in pregnancy (yes: 1/ no:
0); children under 5 years (no: 0/ yes: 1); parity (until 2: 0/  3: 1); prenatal care (yes: 0/ no: 1); weight gain
at pregnancy (kg); initial BMI (kg/m2); final BMI (kg/m2); smoking (daily) (no: 0/ yes,  1 cigarettes: 1);
smoking until (never or not in pregnancy: 0/ first to third trimester: 1); antenatal substance abuse (never: 0/
yes or before pregnancy: 1); periodontal infection (yes: 1/ no: 0); vaginal bleeding (yes: 1/ no: 0); anaemia
(yes: 1/ no: 0); chronic hypertension (yes: 1/ no: 0); chronic diabetes (yes: 1/ no: 0); gestational diabetes
(yes: 1/ no: 0); gestational hypertension (yes: 1/ no: 0); preeclampsia/eclampsia/HELLP (yes: 1/ no: 0);
hypo/hyperthyroidism (yes: 1/ no: 0); HIV (yes: 1/ no: 0); cardiac disease (yes: 1/ no: 0); renal disease (yes:
1/ no: 0); lung diseases (yes: 1/ no: 0); epilepsy (yes: 1/ no: 0); systemic lupus erythematosus (yes: 1/ no:
0); thrombophilia or thrombosis (yes: 1/ no: 0); multiple pregnancy (yes: 1/ no: 0).
Variables included after the adjustment of the model due to the number of missing values (all non-
significant): Schooling (<12:1/12:0); vulvovaginitis (bacterial vaginosis: 1/ no: 0); vulvovaginitis
(candidiasis: 1/ no: 0); urinary tract infection (yes: 1/ no: 0); short cervix (yes: 1/ no: 0); cervical insufficiency
(yes: 1/ no: 0); cerclage (yes: 1/ no: 0); uterine fibroid (yes: 1/ no: 0).
doi:10.1371/journal.pone.0148244.t006
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access to prenatal care, adhering strictly to medical appointments. Owing to higher education,
they have a better self-perception of risk, undergoing more fertility treatments due to advanced
age, resulting in a higher proportion of multiple births.
Some possible limitations of this study do exist. First, the evaluation of antenatal corticoste-
roid use according to WHO gestational age subcategories could be misinterpreted. The per-
centage of corticosteroid use was probably underestimated in women with pi-PTB below 28
weeks because there is no evidence-based indication below 24 weeks [46]. In fact, none of these
women received ACS (n = 11, data not shown). Additionally, the moderate to late preterm sub-
category (32–36 weeks) includes gestational age when ACS use is not recommended (34–36),
underestimating its use. However, ACS was used in almost three-quarters of the 28–31 week
group. Although this is not yet an ideal rate for a pi-PTB, it was significantly higher than ACS
provided to one-third of preterm births in Brazil, as reported by the WHOMulticountry Sur-
vey [47]. It is worth mentioning that some pi-PTBs had urgent indication, with insufficient
time for a complete ACS regimen. Second, although the study was conducted in 20 referral
facilities throughout Brazil, definitely this is not a population study. The higher prevalence of
high-risk pregnant women in participating centres weakened sample representativeness for the
entire Brazilian population. Finally, weight gain during pregnancy would be better assessed if
the weight gain pattern had been used separately by different BMI categories, since suitability
of weight gain depends on the initial maternal BMI [48]. This point is planned to be the focus
for a further in depth secondary analysis, as is also the case for fetal malformations, multiple
pregnancies and some other very specific conditions.
Neonatal outcomes in pi-PTB are dependent on some antenatal factors, including gesta-
tional age, multiple pregnancies, ACS use, maternal complications (preeclampsia, HELLP syn-
drome, chronic hypertension, diabetes, infection, etc.) and fetal complications (malformation,
FGR or fetal distress). In the WHOMulticountry Survey, the risk of early neonatal death in
sPTB infants was shown to be lower than in pi-PTB infants [49]. Maternal and fetal compro-
mise before delivery may determine worse outcomes. The higher prevalence (6-fold) of late
preterm neonatal death compared to term neonates indicate that an alternative approach for
decision-making strategies and high-quality neonatal support for this group should be consid-
ered [26].
The main strengths of EMIP study were the high number of cases, and validation and cross-
checking rules of data collection for more than 300 variables, allowing analysis of the Brazilian
preterm background with high-quality reliable data. To the best of our knowledge, there is no
other official data on determinants of preterm birth in Brazil with such a comprehensive
approach. Therefore, the EMIP database is extremely important to assess conditions related to
pi-PTB, at least for the Brazilian population. Recognition of conditions related to pi-PTB, eval-
uation of perinatal outcomes, reassessment of correlated clinical practices and management
protocols are the key to making progress in primary, secondary and tertiary preventions of pre-
term birth [15,17,18].
What is already known on this subject
Provider-initiated preterm birth is gaining more importance in recent decades, since major
efforts to prevent preterm births have achieved limited results. The proportion of pi-PTB has
increased with decreasing neonatal mortality and increasing Human Development Index.
Some conditions, including advanced maternal age, preeclampsia, previous caesarean section,
placenta previa and hypertension were identified as risk factors for pi-PTB. There is no previ-
ous comprehensive study specifically exploring this preterm birth subtype and its associated
factors. In-depth knowledge of underlying conditions associated with pi-PTB is essential to
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improve preventive strategies for pi-PTB and consequently preterm birth, that no longer occur
only in high-income, but also in low and middle-income settings.
What this study adds
Identifying factors associated with pi-PTB contributes to strategies for preterm birth preven-
tion, including preconception care package, high-risk pregnancy screening, and human and
material resources required for obstetric and neonatal care facilities. The proportion of pi-PTB
is also already high among all preterm births in a middle-income country, as probably occurs
in other similar settings. The need for future larger studies is highlighted to build a real profile
of these conditions and understand how to implement primary and secondary pi-PTB
prevention.
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